东北制药集团股份有限公司XX年年度报告.docxVIP

东北制药集团股份有限公司XX年年度报告 　　期末案例分析：　　东北制药　　财务报表分析　　目录　　一、东北制药简介················································3　　1、东北制药简介················································3　　2、医药行业五力模型分析········································3　　、新进入者的威胁············································3　　、现有竞争者之间的竞争········································3　　、购买商的讨价还价能力·······································4　　、供应商的讨价还价能力········································4　　、替代品的威胁················································4　　二、东北制药会计分析·············································4　　1、VC回归给东北制药带来的主要变动·································5　　2、营业收入与应收账款分析·········································6　　3、资产减值损失明细················································6　　4、现金流量分析·····················································7　　5、分红扩股的策略分析···············································8　　三、东北制药财务分析················································9　　1、与过去相比的纵向分析············································9　　、财务报表分析··················································9　　、利润表分析····················································9　　2、比率分析·····················································10　　、杜邦分析·····················································10　　、获利能力分析················································10　　、经营能力分析················································11　　、偿债能力分析················································11　　、发展能力分析················································12　　四、总结····························································12　　一、东北制药简介　　1、东北制药简介　　东北制药集团股份有限公司，简称“东北制药”，是以化学原料药为主，兼有生物发酵、中西药制剂和微生态制剂的大型综合性制药企业。公司股票上市证券交易所：深圳证券交易所，股票代码：。　　东北制药正式成立于1993年6月，是沈阳市首批试点股份制企业之一、XX年中国500强企业之一、XX年中国制造业500强企业之一。XX年被世界品牌实验室评为中国医药类十大品牌，并以价值亿元位居XX年《中国500最具价值品牌》排行榜第247位。此外，企业还被评为国家级“连续20年守合同重信用企业”、辽宁省“高新技术企业”、外贸出口特殊贡献奖特等奖、优秀纳税企业等众多荣誉。　　企业资产总额60亿元，从业人员11000余人，年销售收入56亿元，年自营出口创汇2亿多美元。　　东北制药设有国家级企业技术开发中心，拥有医药工业研究院、设计院、环保研究所和质量检测中心，并设有“博士后”工作站，具有较强的新药开发能力。拥有集批发、配送、调拨、零售、仓储和商务中心为一体，辐射东北